Sponsored by:

Molecular Imaging: Page 328

New PET tracers can help identify Alzheimer's lesions
By Wayne Forrest
Researchers are reporting positive results with two new PET tracers being developed to help diagnose Alzheimer's disease. The tracers, flutemetamol and florbetapir, may enable earlier diagnosis of Alzheimer's by identifying beta-amyloid plaque in brain tissue, according to two studies published July 11 in Archives of Neurology.
July 10, 2011
Zecotek nets PET patent
By AuntMinnie.com staff writers
Nuclear medicine firm Zecotek Photonics has received a patent on its technology for enhancing the performance of PET scanning and other medical imaging systems.
July 7, 2011
Sofie awarded DOE grant
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has received a grant from the U.S. Department of Energy (DOE) to advance the development of a benchtop, PC-controlled, microscale, chip-based commercial device for the on-demand production of PET radiopharmaceutical probes.
July 7, 2011
CMS targets imaging again; AECL deal ignores moly plight; new AuntMinnieMobile upgrade
By Brian Casey
July 6, 2011
AECL sale does not include NRU reactor
By AuntMinnie.com staff writers
The Canadian government has reached a deal to sell assets in its Atomic Energy of Canada (AECL) commercial reactor division to SNC-Lavalin Group. The sale does not include the National Research Universal (NRU) reactor, however, which supplies molybdenum to North America.
July 6, 2011
Eckert & Ziegler to buy Bioscan unit
By AuntMinnie.com staff writers
Eckert & Ziegler Radiopharma has reached an agreement to acquire Bioscan's radiopharmaceutical equipment business.
July 5, 2011
FDG-PET has low radiation risk to fetus in pregnant patients
By Wayne Forrest
While radiation exposure to a fetus from an FDG-PET scan is low, every effort should be made to minimize exposure by modifying the imaging protocol, according to a study in the July issue of the Journal of Nuclear Medicine.
July 4, 2011
2011 07 01 14 43 34 514 Fdg Pet Fetus Thumb
Survey shows regional imaging cost disparity
By AuntMinnie.com staff writers
Employee healthcare benefits advisory firm Change:Healthcare found significant regional disparity in the cost of imaging studies in the U.S. in its quarterly Healthcare Transparency Index.
July 3, 2011
Lantheus launches phase III flurpiridaz F-18 trial
By AuntMinnie.com staff writers
Lantheus Medical Imaging has launched the first of two phase III clinical trials of a PET radiopharmaceutical for use in detecting coronary artery disease.
June 29, 2011
PET/CT aids in treatment of neuroblastoma
By AuntMinnie.com staff writers
British researchers are using PET/CT to select children with primary refractory or relapsed high-risk neuroblastoma for treatment with a molecular radiotherapy known as lutetium-177 (Lu-177) DOTATATE, according to a study published in the July issue of the Journal of Nuclear Medicine.
June 29, 2011
Aspect Imaging partners with Cage
By AuntMinnie.com staff writers
Aspect Imaging has signed an agreement with Cage Chemicals to develop and manufacture Aspect's PhenoQuant line of contrast agents for preclinical research.
June 28, 2011
Canadian government to sell AECL
By AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) is about to be sold to SNC-Lavalin Group, according to a June 27 report in the Globe and Mail.
June 28, 2011
Previous Page
Page 328 of 612
Next Page